Influenza virus immunization effectivity in kidney transplant patients subjected to two different triple-drug therapy immunosuppression protocols - Mycophenolate versus azathioprine
Ai. Sanchez-fructuoso et al., Influenza virus immunization effectivity in kidney transplant patients subjected to two different triple-drug therapy immunosuppression protocols - Mycophenolate versus azathioprine, TRANSPLANT, 69(3), 2000, pp. 436-439
Background. Due to possible complications and treatment limitations, the pr
evention of influenza in renal transplant (RT) patients is highly indicated
.
Methods, Forty-nine patients with a 1-year functioning RT subjected to two
different immunosuppressive regimens and 37 healthy relatives (HR) were adm
inistered the anti-influenza vaccine as recommended for 1996 to 1997. Anti-
influenza antibody, creatinine, and immunological markers were estimated at
1 and 3 months after vaccination.
Results, Three months after vaccination, 46.2% of the RT patients and 69% o
f the HR (P=0.06) showed protective antibody titers to influenza A (relativ
e risk [RR]; 0.67; 95% confidence interval: 0.4-1.02), A total of 20.5% of
the RT patients and 44.8% of the HR showed antibodies to influenza B (P=0.0
3). Despite these differences, the incidence of illness was similar. The im
munosuppressive regimen had no effect on the antibody response.
Conclusions. Although the RT patients showed a reduced antibody response, n
o negative effects on graft outcome were observed.